Antecedent immunosuppressive therapy for immune-mediated inflammatory diseases in the setting of a COVID-19 outbreakArticle Published on 2020-12-012023-07-13 Journal: Journal of the American Academy of Dermatology [Category] SARS, [키워드] Autoimmune disease biologics coronavirus COVID-19 DMARDs Immune-mediated inflammatory diseases Immunosuppression SARS-CoV-2 [DOI] 10.1016/j.jaad.2020.07.089 PMC 바로가기